down arrow

Concord Biotech

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,660.00
59.35 (3.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 68.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
244.22
310.18
215.80
318.97
240.80
262.35
194.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
244.22
310.18
215.80
318.97
240.80
262.35
194.83
Raw Material Cost
60.96
68.05
55.03
55.67
47.39
42.00
39.48
Purchase of Finished goods
12.19
21.70
11.78
11.45
23.22
10.48
11.60
(Increase) / Decrease In Stocks
-20.75
-13.44
-18.51
21.73
-23.52
0.39
-10.67
Employee Cost
34.64
33.66
31.66
33.96
30.67
30.17
28.25
Power Cost
26.44
29.23
0.00
0.00
27.40
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
-0.01
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
32.79
34.30
54.56
61.88
29.70
60.11
54.03
Total Expenditure (Excl Depreciation)
146.27
173.51
134.52
184.68
134.86
143.15
122.68
Operating Profit (PBDIT) excl Other Income
97.95
136.67
81.28
134.29
105.94
119.20
72.15
Other Income
14.73
10.03
10.31
10.81
8.19
8.13
6.65
Operating Profit (PBDIT)
112.68
146.70
91.59
145.10
114.13
127.33
78.80
Interest
0.10
0.10
0.24
0.46
0.50
0.84
0.75
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
112.58
146.60
91.35
144.64
113.63
126.49
78.05
Depreciation
13.26
13.31
13.18
13.72
13.54
13.30
13.04
Profit Before Tax
101.15
130.34
79.52
128.72
103.10
109.70
71.04
Tax
25.23
34.59
19.93
33.70
25.53
28.68
16.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
74.09
98.70
58.24
97.22
74.55
84.49
48.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
74.09
98.70
58.24
97.22
74.55
84.49
48.47
Share in Profit of Associates
1.83
-2.96
1.35
-2.20
3.02
-3.47
6.02
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
75.92
95.74
59.59
95.02
77.57
81.02
54.49
Equity Capital
10.46
10.46
10.46
10.46
10.46
10.46
10.46
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.26
9.15
5.7
9.08
7.42
7.75
5.21
Diluted Earnings per share
7.26
9.15
5.7
9.08
7.41
7.74
5.21
Operating Profit Margin (Excl OI)
40.11%
44.06%
37.66%
42.1%
44.0%
45.44%
37.03%
Gross Profit Margin
46.1%
47.26%
42.33%
45.35%
47.19%
48.21%
40.06%
PAT Margin
31.09%
30.87%
27.61%
29.79%
32.21%
30.88%
27.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2024 is -21.27% vs 43.73% in Sep 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2024 is -20.70% vs 60.66% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is -28.33% vs 68.15% in Sep 2024

stock-summary

Interest

QoQ Growth in quarter ended Dec 2024 is 0.00% vs -58.33% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

Compare Quarterly Results Of Concord Biotech With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
244.22
3,230.00
-2,985.78
-92.44%
Other Operating Income
0.00
0.00
0.00
Total Operating income
244.22
3,230.00
-2,985.78
-92.44%
Raw Material Cost
60.96
536.11
-475.15
-88.63%
Purchase of Finished goods
12.19
387.30
-375.11
-96.85%
(Increase) / Decrease In Stocks
-20.75
11.81
-32.56
-275.70%
Employee Cost
34.64
709.71
-675.07
-95.12%
Power Cost
26.44
0.00
26.44
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
32.79
755.27
-722.48
-95.66%
Total Expenditure (Excl Depreciation)
146.27
2,400.20
-2,253.93
-93.91%
Operating Profit (PBDIT) excl Other Income
97.95
829.80
-731.85
-88.20%
Other Income
14.73
77.32
-62.59
-80.95%
Operating Profit (PBDIT)
112.68
907.12
-794.44
-87.58%
Interest
0.10
220.93
-220.83
-99.95%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
112.58
686.19
-573.61
-83.59%
Depreciation
13.26
192.30
-179.04
-93.10%
Profit Before Tax
101.15
497.33
-396.18
-79.66%
Tax
25.23
112.81
-87.58
-77.63%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
74.09
381.08
-306.99
-80.56%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
74.09
381.08
-306.99
-80.56%
Share in Profit of Associates
1.83
3.44
-1.61
-46.80%
Minority Interest
0.00
4.29
-4.29
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
75.92
380.23
-304.31
-80.03%
Equity Capital
10.46
40.06
-29.60
-73.89%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.26
9.49
-2.23
-23.50%
Diluted Earnings per share
7.26
9.44
-2.18
-23.09%
Operating Profit Margin (Excl OI)
40.11%
25.69%
0.00
14.42%
Gross Profit Margin
46.10%
21.24%
0.00
24.86%
PAT Margin
31.09%
11.90%
0.00
19.19%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 244.22 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -21.27% vs 43.73% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 1.42% vs 0.05% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 75.92 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -20.70% vs 60.66% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -2.13% vs 0.26% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 97.95 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -28.33% vs 68.15% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -7.54% vs -5.14% in Dec 2023

Quarterly - Interest
Interest 0.10 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 0.00% vs -58.33% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -80.00% vs -45.05% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 40.11%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023